HomeAI · summaries
Storia in 4 fonti
Ozempic Is Finally Turning the Tide Against Obesity, New Data Shows
As the rate of GLP-1 prescriptions in the U.S. has risen, the obesity rate has dropped.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
forbes.com
Employer Co-Pays For GLP-1 Weight Loss Drugs To Rise If They’re Covered
GLP-1 weight loss drugs like Ozempic, Zepbound and Wegovy are the biggest contributor to rising prescription spending. And that will trigger co-payments to rise.
- ·
elmundo.es
La revoluci�n de los f�rmacos de la familia Ozempic: as� son sus efectos en todo el cuerpo
Cada nuevo f�rmaco antiobesidad llega con la promesa de una mayor reducci�n de peso. Esta semana, la �ltima generaci�n de la familia del famoso Ozempic romp�a r�cords al...
